Vδ2 T-lymphocyte responses in cord blood samples from Italy and Côte d'Ivoire

Immunology

Volumn 124, Issue 3, 2008, Pages 380-387

  Cairo, Cristiana ^a   Mancino, Giorgio ^b   Cappelli, Giulia ^c   Pauza, C David ^a   Galli, Elena ^b   Brunetti, Ercole ^b   Colizzi, Vittorio ^d,e  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b FATEBENEFRATELLI HOSPITAL   (Italy)

^c CNR   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e Centre Integrée de Recherches Bioclinique d'Abidjan   (Côte d’Ivoire)

Author keywords

Aminobisphosphonates; Bacille Calmette Gu rin; Cord blood; Gammadelta; T lymphocytes

Indexed keywords

BCG VACCINE; BISPHOSPHONIC ACID DERIVATIVE; CYTOKINE; PAMIDRONIC ACID; T LYMPHOCYTE RECEPTOR DELTA CHAIN; BACTERIAL ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; BACTERIUM; BLOOD SAMPLING; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLULAR IMMUNITY; COTE D'IVOIRE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREACTIVITY; ITALY; LYMPHOCYTE CULTURE; MEMORY CELL; MONONUCLEAR CELL; NEWBORN; PRIORITY JOURNAL; PROTOZOON; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UMBILICAL CORD BLOOD; BLOOD; CELL CULTURE; CLINICAL TRIAL; DRUG EFFECT; FEMALE; FETUS BLOOD; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; MULTICENTER STUDY; MYCOBACTERIUM BOVIS; PREGNANCY; PRENATAL EXPOSURE; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, BACTERIAL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COTE D'IVOIRE; DIPHOSPHONATES; FEMALE; FETAL BLOOD; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; ITALY; LYMPHOCYTE ACTIVATION; MYCOBACTERIUM BOVIS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS;

EID: 44849108984     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2007.02784.x     Document Type: Article

References (39)

1. Prescott SL, Macaubas C, Holt BJ, Smallacombe TB, Loh R, Sly PD, Holt PG. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. J Immunol 1998 160: 4730 7.
2. Harris DT, Schumacher MJ, Locascio J et al. Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc Natl Acad Sci USA 1992 89: 10006 10.
3. Adkins B. T-cell function in newborn mice and humans. Immunol Today 1999 20: 330 5.
4. Romani N, Reider D, Heuer M, Ebner S, Kampgen E, Eibl B, Niederwieser D, Schuler G. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods 1996 196: 137 51.
5. Morita CT, Parker CM, Brenner MB, Band H. TCR usage and functional capabilities of human gamma delta T cells at birth. J Immunol 1994 153: 3979 88.
6. Parker CM, Groh V, Band H et al. Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire. J Exp Med 1990 171: 1597 612.
7. Tanaka Y, Sano S, Nieves E et al. Nonpeptide ligands for human gamma delta T cells. Proc Natl Acad Sci USA 1994 91: 8175 9.
8. Tanaka Y, Morita CT, Nieves E, Brenner MB, Bloom BR. Natural and synthetic nonpeptide antigens recognized by human gamma-delta T-cells. Nature 1995 375: 155 8.
9. Eberl M, Hintz M, Reichenberg A, Kollas AK, Wiesner J, Jomaa H. Microbial isoprenoid biosynthesis and human gammadelta T cell activation. FEBS Lett 2003 544: 4 10.
10. Morita CT, Beckman EM, Bukowski JF, Tanaka Y, Band H, Bloom BR, Golan DE, Brenner MB. Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta T cells. Immunity 1995 3: 495 507.
11. Bukowski JF, Morita CT, Band H, Brenner MB. Crucial role of TCR gamma chain junctional region in prenyl pyrophosphate antigen recognition by gamma delta T cells. J Immunol 1998 161: 286 93.
12. Kunzmann V, Bauer E, Wilhelm M. Gamma/delta T-cell stimulation by pamidronate. N Engl J Med 1999 340: 737 8.
13. Gober HJ, Kistowska M, Angman L, Jeno P, Mori L, De Libero G. Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells. J Exp Med 2003 197: 163 8.
14. Schild H, Mavaddat N, Litzenberger C et al. The nature of major histocompatibility complex recognition by gamma delta T cells. Cell 1994 76: 29 37.
15. Gioia C, Agrati C, Casetti R et al. Lack of CD27- CD45RA- V gamma 9V delta 2+ T cell effectors in immunocompromised hosts and during active pulmonary tuberculosis. J Immunol 2002 168: 1484 9.
16. Carena I, Shamshiev A, Donda A, Colonna M, Libero GD. Major histocompatibility complex class I molecules modulate activation threshold and early signaling of T cell antigen receptor-gamma/delta stimulated by nonpeptidic ligands. J Exp Med 1997 186: 1769 74.
17. Poccia F, Cipriani B, Vendetti S et al. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9 V delta 2 T lymphocytes. J Immunol 1997 159: 6009 17.
18. Montesano C, Gioia C, Martini F, Agrati C, Cairo C, Pucillo LP, Colizzi V, Poccia F. Antiviral activity and anergy of gammadelta T lymphocytes in cord blood and immuno-compromised host. J Biol Regul Homeost Agents 2001 15: 257 64.
19. Engelmann I, Moeller U, Santamaria A, Kremsner PG, Luty AJ. Differing activation status and immune effector molecule expression profiles of neonatal and maternal lymphocytes in an African population. Immunology 2006 119: 515 21.
20. Kunzmann V, Bauer E, Feurle J, Weissinger F, Tony HP, Wilhelm M. Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood 2000 96: 384 92.
21. Miyagawa F, Tanaka Y, Yamashita S, Minato N. Essential requirement of antigen presentation by monocyte lineage cells for the activation of primary human gamma delta T cells by aminobisphosphonate antigen. J Immunol 2001 166: 5508 14.
22. Behr C, Dubois P. Preferential expansion of V gamma 9 V delta 2 T cells following stimulation of peripheral blood lymphocytes with extracts of Plasmodium falciparum. Int Immunol 1992 4: 361 6.
23. Behr C, Poupot R, Peyrat MA, Poquet Y, Constant P, Dubois P, Bonneville M, Fournie JJ. Plasmodium falciparum stimuli for human gammadelta T cells are related to phosphorylated antigens of mycobacteria. Infect Immun 1996 64: 2892 6.
24. Rubio G, Aramburu J, Ontanon J, Lopez-Botet M, Aparicio P. A novel functional cell surface dimer (kp43) serves as accessory molecule for the activation of a subset of human gamma delta T cells. J Immunol 1993 151: 1312 21.
25. Caccamo N, Meraviglia S, Ferlazzo V et al. Differential requirements for antigen or homeostatic cytokines for proliferation and differentiation of human Vgamma9 Vdelta2 naive, memory and effector T cell subsets. Eur J Immunol 2005 35: 1764 72.
26. Kim KD, Lee HG, Kim JK et al. Enhanced antigen-presenting activity and tumour necrosis factor-alpha-independent activation of dendritic cells following treatment with Mycobacterium bovis bacillus Calmette-Guérin. Immunology 1999 97: 626 33.
27. Liu E, Law HK, Lau YL. BCG promotes cord blood monocyte-derived dendritic cell maturation with nuclear Rel-B up-regulation and cytosolic I kappa B alpha and beta degradation. Pediatr Res 2003 54: 105 12.
28. Thurnher M, Ramoner R, Gastl G, Radmayr C, Bock G, Herold M, Klocker H, Bartsch G. Bacillus Calmette-Guérin mycobacteria stimulate human blood dendritic cells. Int J Cancer 1997 70: 128 34.
29. Wang J, Wakeham J, Harkness R, Xing Z. Macrophages are a significant source of type 1 cytokines during mycobacterial infection. J Clin Invest 1999 103: 1023 9.
30. Boom WH, Chervenak KA, Mincek MA, Ellner JJ. Role of the mononuclear phagocyte as an antigen-presenting cell for human gamma delta T cells activated by live Mycobacterium tuberculosis. Infect Immun 1992 60: 3480 8.
31. Balaji KN, Boom WH. Processing of Mycobacterium tuberculosis bacilli by human monocytes for CD4+ alphabeta and gammadelta T cells: role of particulate antigen. Infect Immun 1998 66: 98 106.
32. Rojas RE, Torres M, Fournie JJ, Harding CV, Boom WH. Phosphoantigen presentation by macrophages to Mycobacterium tuberculosis- reactive Vgamma9Vdelta2 + T cells: modulation by chloroquine. Infect Immun 2002 70: 4019 27.
33. Wolf AM, Rumpold H, Tilg H, Gastl G, Gunsilius E, Wolf D. The effect of zoledronic acid on the function and differentiation of myeloid cells. Haematologica 2006 91: 1165 71.
34. Fiore F, Castella B, Nuschak B et al. Enhanced ability of dendritic cells to stimulate innate and adaptive immunity on short-term incubation with zoledronic acid. Blood 2007 110: 921 7.
35. Camus D, Carlier Y, Bina JC, Borojevic R, Prata A, Capron A. Sensitization to Schistosoma mansoni antigen in uninfected children born to infected mothers. J Infect Dis 1976 134: 405 8.
36. Gill TJ III, Repetti CF, Metlay LA, Rabin BS, Taylor FH, Thompson DS, Cortese AL. Transplacental immunization of the human fetus to tetanus by immunization of the mother. J Clin Invest 1983 72: 987 96.
37. Dent A, Malhotra I, Mungai P, Muchiri E, Crabb BS, Kazura JW, King CL. Prenatal malaria immune experience affects acquisition of Plasmodium falciparum merozoite surface protein-1 invasion inhibitory antibodies during infancy. J Immunol 2006 177: 7139 45.
38. Malhotra I, Mungai P, Wamachi A, Kioko J, Ouma JH, Kazura JW, King CL. Helminth- and Bacillus Calmette-Guérin-induced immunity in children sensitized in utero to filariasis and schistosomiasis. J Immunol 1999 162: 6843 8.
39. Boullier S, Poquet Y, Halary F, Bonneville M, Fournie JJ, Gougeon ML. Phosphoantigen activation induces surface translocation of intracellular CD94/NKG2A class I receptor on CD94- peripheral Vgamma9 Vdelta2 T cells but not on CD94- thymic or mature gammadelta T cell clones. Eur J Immunol 1998 28: 3399 410.